The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Psoriasis Tied to Increased Risk of Major Depression

Psoriasis Tied to Increased Risk of Major Depression

October 8, 2015 • By Will Boggs, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—People with psoriasis are twice as likely as others to have major depression, according to data from the National Health and Nutrition Examination Survey (NHANES).

You Might Also Like
  • Within Our Reach–Funded Study Finds Increased Depression Risk Among Some RA Patients
  • Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine
  • Psoriasis Tied to Higher Risk of Serious Liver Disease

In earlier work, psoriasis has been linked to depression, anxiety and substance abuse. Studies have shown that both depression and psoriasis are associated with cardiovascular disease, which could confound the association between the two.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Roger S. Ho and colleagues from New York University School of Medicine used data from NHANES 2009–2012 to investigate the relationship between psoriasis and major depression after adjusting for multiple cardiovascular risk factors.

Their study of more than 12,300 patients included 351 (2.8%) with psoriasis and 968 (7.8%) with major depression. Mean Patient Health Questionnaire-9 (PHQ-9) depression scores were significantly higher among patients with psoriasis than among those without the disease (4.54 vs. 3.22, p<0.001).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Major depression was twice as common among patients with psoriasis after adjustment for sex, age, race, body mass index, physical activity, history of smoking, alcohol use, myocardial infarction, stroke and diabetes, the researchers report in JAMA Dermatology, online Sept. 30.

Patients with psoriasis were also 44% more likely to report that any symptoms of depression caused significant daily functional impairment compared with patients without the skin disease. And they tended to report suicidal ideation more often, although this difference fell short of statistical significance.

The prevalence of major depression did not differ significantly between patients with limited psoriasis (18.4%) and patients with extensive psoriasis (23.1%).

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“Therefore,” the researchers conclude, “our study supports that all patients with psoriasis, regardless of severity, are at risk for depressive symptoms and may benefit from depression screening.”

Dr. Dafna Gladman, a rheumatologist at the University of Toronto in Canada, told Reuters Health by email, “We have shown that patients with psoriasis and psoriatic arthritis have a higher risk of depression than those with psoriasis without arthritis. It is clear that psoriasis is not just a skin disease; it is a condition which is associated with a number of comorbidities.”

“Unfortunately from a population based study one cannot ascertain the relationship between the severity of the psoriasis and the depression, nor whether patients were treated for either depression or their psoriasis,” Dr. Gladman said.

“We screen all patients for depression by at least asking them whether they have been depressed and whether they are taking medications for depression, and occasionally using a depression questionnaire,” Dr. Gladman said. “I would suggest that family physicians and dermatologists should be alert to the possibility of depression and therefore address this issue with their patients.”

Pages: 1 2 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Depression, Mental Health, Psoriasis

You Might Also Like:
  • Within Our Reach–Funded Study Finds Increased Depression Risk Among Some RA Patients
  • Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine
  • Psoriasis Tied to Higher Risk of Serious Liver Disease
  • TNF Inhibitor Tied to Lower Cardiovascular Risk in Psoriasis

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)